Back
Ascendis Pharma AS Stock Predictions
Sponsored
ASND
Sponsored
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
20
ASND
Ascendis Pharma AS
Last Price:
122.25
Seasonality Move:
20.86%
7 Day Trial
ALL ACCESS PASS
$
7
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Ascendis Pharma AS Stock Forecast
- Over the next 52 weeks, Ascendis Pharma AS has on average historically risen by 30.5% based on the past 9 years of stock performance.
- Ascendis Pharma AS has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Ascendis Pharma AS Stock Undervalued?
The current Ascendis Pharma AS [ASND] share price is $124.38. The Score for ASND is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. - ASND is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Ascendis Pharma AS Stock Go Up Next Year?
- Over the next 52 weeks, Ascendis Pharma AS has on average historically risen by 30.5% based on the past 9 years of stock performance.
Ascendis Pharma AS Stock Rating
Sell
20
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS overpriced?
- Ascendis Pharma AS has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Ascendis Pharma AS Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ascendispharma.com
52-Week Data
52-Week High:
161.00
52-Week Low:
90.13
Prediction Charts
Market Cap:
7.43B
Price in USD:
124.38
Volume:
304.17K
Beta:
0.64
Technical Analysis
SMA50:
132.55
SMA100:
133.05
SMA200:
136.92
52-Wk Change:
32.66%
Stock Predictions
-
Is Ascendis Pharma AS stock public?
Yes, Ascendis Pharma AS is a publicly traded company. -
What is the Ascendis Pharma AS stock quote today?
The Ascendis Pharma AS stock price is 124.38 USD today. -
How to buy Ascendis Pharma AS stock online?
You can buy Ascendis Pharma AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-1 | 124.04 | 125.28 | 125.94 | 121.51 |
Nov-4 | 127.20 | 125.61 | 129.17 | 123.03 |
Nov-5 | 124.52 | 128.13 | 129.31 | 122.13 |
Nov-6 | 130.50 | 129.36 | 132.46 | 126.71 |
Nov-7 | 129.28 | 126.55 | 129.28 | 126.26 |
Nov-8 | 127.40 | 124.33 | 128.20 | 124.11 |
Nov-11 | 124.83 | 128.69 | 129.81 | 124.45 |
Nov-12 | 127.39 | 127.67 | 129.51 | 125.40 |
Nov-13 | 128.50 | 126.03 | 129.86 | 125.15 |
Nov-14 | 126.10 | 124.28 | 127.56 | 124.20 |
Nov-15 | 118.98 | 126.51 | 133.00 | 118.05 |
Nov-18 | 127.34 | 122.00 | 127.34 | 120.73 |
Nov-19 | 120.11 | 124.44 | 125.06 | 119.09 |
Nov-20 | 124.44 | 124.38 | 125.52 | 122.31 |
Ascendis Pharma AS Earnings
Ascendis Pharma AS Earnings Report: Per Share Ascendis Pharma AS Earnings Q1 Q2 Q3 and Q4 last year and next year.
Ascendis Pharma AS Forecast Revenue Growth
Ascendis Pharma AS Stock Analysis: Historical quarterly revenues per share for Ascendis Pharma AS and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.89 per share, and an increase next year of $4.01 per share.
* Ascendis Pharma AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.